BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12115369)

  • 21. Can the Gail model increase the predictive value of a positive mammogram in a European population screening setting? Results from a Spanish cohort.
    Buron A; Vernet M; Roman M; Checa MA; Pérez JM; Sala M; Comas M; Murta-Nascimiento C; Castells X; Macià F
    Breast; 2013 Feb; 22(1):83-8. PubMed ID: 23141024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammographic screening: patterns of use and estimated impact on breast carcinoma survival.
    Blanchard K; Colbert JA; Puri D; Weissman J; Moy B; Kopans DB; Kaine EM; Moore RH; Halpern EF; Hughes KS; Tanabe KK; Smith BL; Michaelson JS
    Cancer; 2004 Aug; 101(3):495-507. PubMed ID: 15274062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
    Taplin SH; Ichikawa L; Yood MU; Manos MM; Geiger AM; Weinmann S; Gilbert J; Mouchawar J; Leyden WA; Altaras R; Beverly RK; Casso D; Westbrook EO; Bischoff K; Zapka JG; Barlow WE
    J Natl Cancer Inst; 2004 Oct; 96(20):1518-27. PubMed ID: 15494602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
    JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term risk of false-positive screening results and subsequent biopsy as a function of mammography use.
    Blanchard K; Colbert JA; Kopans DB; Moore R; Halpern EF; Hughes KS; Smith BL; Tanabe KK; Michaelson JS
    Radiology; 2006 Aug; 240(2):335-42. PubMed ID: 16864665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer?
    Mandelblatt JS; Stout N; Trentham-Dietz A
    Ann Intern Med; 2011 Jul; 155(1):58-60. PubMed ID: 21727294
    [No Abstract]   [Full Text] [Related]  

  • 27. An integrated breast cancer risk assessment and management model based on fuzzy cognitive maps.
    Subramanian J; Karmegam A; Papageorgiou E; Papandrianos N; Vasukie A
    Comput Methods Programs Biomed; 2015 Mar; 118(3):280-97. PubMed ID: 25697987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening Mammography: Patient Perceptions and Preferences Regarding Communication of Estimated Breast Cancer Risk.
    Amornsiripanitch N; Mangano M; Niell BL
    AJR Am J Roentgenol; 2017 May; 208(5):1163-1170. PubMed ID: 28225643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physician recommendations for screening mammography: results of a survey using clinical vignettes.
    Hamblin JE
    J Fam Pract; 1991 May; 32(5):472-7. PubMed ID: 2022935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age as a factor in breast cancer knowledge, attitudes and screening behaviour.
    Mah Z; Bryant H
    CMAJ; 1992 Jun; 146(12):2167-74. PubMed ID: 1308756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mammography].
    Grégoire A; Bernard C; Lavallée G; Morin C; Philie M
    Union Med Can; 1992; 121(4):239-42. PubMed ID: 1413293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer.
    Mackay J; Rogers C; Fielder H; Blamey R; Macmillan D; Boggis C; Brown J; Pharoah PD; Moss S; Day NE; Myles J; Austoker J; Gray J; Cuzick J; Duffy SW
    J Epidemiol Biostat; 2001; 6(5):365-9; discussion 371-5. PubMed ID: 11822726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survey on mammographic screening among women aged 40 to 65 years old at polyclinics.
    Leong HS; Heng R; Emmanuel SC
    Singapore Med J; 2007 Jan; 48(1):34-40. PubMed ID: 17245514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.
    Kerlikowske K; Ichikawa L; Miglioretti DL; Buist DS; Vacek PM; Smith-Bindman R; Yankaskas B; Carney PA; Ballard-Barbash R;
    J Natl Cancer Inst; 2007 Mar; 99(5):386-95. PubMed ID: 17341730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of mammographic screening relative to the treatment of women with carcinoma of the breast.
    Solin LJ; Legorreta A; Schultz DJ; Zatz S; Goodman RL
    Arch Intern Med; 1994 Apr; 154(7):745-52. PubMed ID: 8147678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast carcinoma stage in relation to time interval since last mammography: a registry-based study. The Romagna Cancer Registry and Collaborators.
    Cancer; 1997 Oct; 80(8):1432-7. PubMed ID: 9338467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammography use and mode of detection among breast cancer patients in Estonia.
    Innos K; Valvere V; Padrik P; Eelma E; Kütner R; Lehtsaar J; Tekkel M
    Women Health; 2016; 56(2):129-40. PubMed ID: 26327255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. USPSTF erroneously understated life-years-gained benefit of mammographic screening of women in their 40s.
    Helvie MA; Petitti DB; Calonge N; Melnyk BM; Wilt TJ
    Radiology; 2011 Mar; 258(3):958-9. PubMed ID: 21339356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.